Loading clinical trials...
Loading clinical trials...
Salvage Therapy With Idarubicin in Immunocompetent Patients With Relapsed or Refractory Primary Central Nervous System Lymphomas
Conditions
Interventions
Idarubicin
Locations
1
Italy
Servizio Radiochemioterapia - Ospedale San Raffaele
Milan, Milan, Italy
Start Date
November 1, 2004
Primary Completion Date
July 1, 2010
Last Updated
July 30, 2010
NCT04161248
NCT06528301
NCT05940272
NCT06534437
NCT05463263
NCT06609304
Lead Sponsor
International Extranodal Lymphoma Study Group (IELSG)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions